However, it now appears clear that engagement of inhibitory receptors such as CTLA-4, PD-1 and Tim-3, expressed on CD8+ tumour-infiltrating lymphocytes (TIL) with their respective ligands on target cells, is another critical constraint explaining the poor reactivity of these cells in the tumour immune context2. This evidence concerns the gene CTLA4 and neoplasm.